Crinetics Pharmaceuticals
Trade Crinetics Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CRNX Key Statistics
Stock Snapshot
With a market cap of 5.73B, Crinetics Pharmaceuticals(CRNX) trades at $55.88. The stock has a price-to-earnings ratio of -12.45.
On 2026-01-16, Crinetics Pharmaceuticals(CRNX) stock moved within a range of $55.28 to $56.40. With shares now at $55.88, the stock is trading +1.1% above its intraday low and -0.9% below the session's peak.
Trading volume for Crinetics Pharmaceuticals(CRNX) stock has reached 74.79K, versus its average volume of 2.23M.
Over the past 52 weeks, Crinetics Pharmaceuticals(CRNX) stock has traded between a high of $57.99 and a low of $24.10.
Over the past 52 weeks, Crinetics Pharmaceuticals(CRNX) stock has traded between a high of $57.99 and a low of $24.10.
CRNX News
Claim 70% Off TipRanks Premium Crinetics Pharmaceuticals ( (CRNX) ) just unveiled an update. On January 13, 2026, Crinetics Pharmaceuticals’ founder and CEO S...